# Major Depressive Disorder In The Elderly

> **NCT00093288** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 364 (—)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** bupropion XL

## Key facts

- **NCT ID:** NCT00093288
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 364 (—)
- **Last updated:** 2013-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093288, "Major Depressive Disorder In The Elderly". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00093288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*